about
Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakStructural basis for differential neutralization of ebolavirusesComplex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light ChainStructure of the Ebola virus glycoprotein bound to an antibody from a human survivorTechniques and tactics used in determining the structure of the trimericebolavirusglycoproteinA shared structural solution for neutralizing ebolavirusesStructure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola VirusHost-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing AntibodiesDevelopment of Prototype Filovirus Recombinant Antigen ImmunoassaysCathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusionStructures of protective antibodies reveal sites of vulnerability on Ebola virus.Structural basis for Marburg virus neutralization by a cross-reactive human antibody.Mechanism of human antibody-mediated neutralization of Marburg virusProtective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsPan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesCross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteIsolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreakStructures of Ebola virus GP and sGP in complex with therapeutic antibodies.Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.An efficient platform for screening expression and crystallization of glycoproteins produced in human cells.Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region.Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionMultifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinEarly Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection
P50
Q24701722-60066B25-D49F-4600-A829-B29D0DCBAFC7Q27014910-102075ED-2EA5-443F-99B5-CD87CF434143Q27649064-F61777BA-D8B4-40AA-88C3-30F55F7D67D3Q27651112-6D920584-0CFA-400E-9A64-E2D3C1BEAE4FQ27658238-435D029B-D39F-4BF5-BF32-8AAE4A992E9BQ27675675-5323B495-FE7B-447C-BD8D-8125011B4923Q27676230-9E17E6B6-767D-4FCA-8FF8-130D169C25E7Q27704173-7DB16602-B5A1-4754-9F1D-B25AAF1D46A0Q28607807-7E54F2B7-2905-40AD-9F6C-BC47E14FA827Q30426228-53AC53A0-AAC6-4C7D-A3AD-DC432C672F35Q34079366-D34B3461-1033-4C5C-A360-5B9AC2A3BF5AQ34661120-8299C804-CEAB-4463-ADD9-B2E540372A91Q35132751-CCFCBB64-35FE-49F9-8616-7B3385878D52Q35132756-66E7A06D-D59C-4197-A370-6238BA3634B5Q35675647-8695BE2C-EA72-41BA-ABC9-A32E659BEC63Q36433920-5A3B271A-0F15-4DD6-9203-5D4BC091BB11Q36522002-51CF4D4D-D22B-4EC7-9213-09AEFDAAC2EAQ36913606-601E4244-6D42-4B6E-BD3F-CDB5BB607495Q36988908-274EBE5F-04E0-495E-87BD-269D73F92430Q37213985-67C6CC4D-E306-4471-9629-A971A591C2D1Q38956790-486C1395-F6A3-480E-BF68-86C57B85BC6DQ39859955-81886D28-5645-4647-9BDD-E4CFDAA67726Q42591160-64CA6E5A-32D8-4842-9BC0-CB69D6C8C3E9Q47555346-B9FFF27B-CBFB-4AA7-8962-49B4E515AC99Q54218743-C6348FB4-4A8E-418C-A9E0-7F0D09F6F830Q56558172-B7E6AE6D-14FC-4370-B83C-75A6DB63D6E5Q56897586-EDE0C1C8-33F1-4BDA-8EDE-E83C768429F6Q64360363-50C166E5-3FD5-4BB5-839B-CA464795A755
P50
name
Marnie L Fusco
@en
Marnie L Fusco
@nl
type
label
Marnie L Fusco
@en
Marnie L Fusco
@nl
prefLabel
Marnie L Fusco
@en
Marnie L Fusco
@nl